In a bold move to combat Nigeria’s persistently low childhood immunisation coverage, Save the Children International, in ...

Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving ...

GSK PLC GSK shares slid 1.10% to £13.95 Wednesday, on what proved to be an all-around poor trading session for the stock ...

A Fierce Pharma Marketing review of the LinkedIn and Instagram pages of the 20 largest pharmas found that, as of Thursday, ...

Bharat Biotech and GSK announce price reduction for the world's first malaria vaccine to under $5. This move aims to improve ...

The US Food and Drug Administration (FDA) has approved GSK's 200 mg/ml autoinjector of Benlysta for individuals aged five ...

GSK has applied to the European Medicines Agency to expand use of its respiratory syncytial virus (RSV) vaccine to adults ...

GSK's marketing application for linerixibat, targeting cholestatic pruritus in PBC patients, gains EMA acceptance based on phase III success.

GSK PLC GSK shares slid 2.06% to £14.50 Wednesday, on what proved to be an all-around positive trading session for the stock ...

As part of a multi-year collaboration, GSK and India’s Bharat Biotech are redoubling their efforts to bring the world’s first malaria vaccine to more countries in need at affordable prices. | The ...